The successful collaboration between ETH Zurich and the Swiss medical technology company Hocoma was awarded with the 2012 Technology Transfer Award at the European Robotics Forum in Denmark last week. The world’s first commercially available robotic arm exoskeleton, the Armeo®Power, provides early rehabilitation for patients with severe neurological movement impairments. The most prestigious prize in European robotics is awarded annually for outstanding innovation and successful technology transfer among science and industry.
ETH ZURICH AND HOCOMA AWARDED FOR ARM EXOSKELETON TECHNOLOGY
14th March 2012
